{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/CEPI/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"CEPI","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CEPI\",,,,,undefined,":{"symbol":"CEPI","market":"US","secType":"STK","nameCN":"REX CRYPTO EQUITY PREMIUM INCOME ETF","latestPrice":32.16,"timestamp":1789997809435,"preClose":31.8501,"halted":0,"volume":6929,"delay":0,"changeRate":0.009729953752107385,"floatShares":3865000,"shares":3865000,"eps":0,"marketStatus":"Trading","change":0.3099,"latestTime":"09-21 09:36:52 EDT","open":32.1,"high":32.175,"low":32.1,"amount":222552.918237,"amplitude":0.002355,"askPrice":32.17,"askSize":400,"bidPrice":32.03,"bidSize":200,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1790020800000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":31.8501,"sharesOutstanding":2715000,"nav":31.21,"aum":120626650,"dividendRate":0.450648,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":32.35,"preClose":31.8501,"latestTime":"09:27 EDT","volume":570,"amount":18394.5099,"timestamp":1789997257874,"change":0.4999,"changeRate":0.015695,"amplitude":0.015071},"postHourTrading":{"tag":"盘后","latestPrice":31.86,"preClose":31.8501,"latestTime":"19:32 EDT","volume":182,"amount":5795.4494,"timestamp":1789774372874,"change":0.0099,"changeRate":0.000311,"amplitude":0},"volumeRatio":8.284141,"impliedVol":0.1895,"impliedVolPercentile":0.3187},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CEPI\",,,,,undefined,":{"symbol":"CEPI","floatShares":3865000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":8.284141,"shares":3865000,"dividePrice":14.492839,"high":32.175,"amplitude":0.002355,"preClose":31.8501,"low":32.1,"week52Low":26.981,"pbRate":"--","week52High":43.7,"institutionHeld":0,"latestPrice":32.16,"committee":-0.333333,"eps":0,"divideRate":0.450648,"volume":6929,"delay":0,"ttmEps":0,"open":32.1,"prevYearClose":33.6685,"prevWeekClose":31.8501,"prevMonthClose":31.2312,"prevQuarterClose":33.88,"fiveDayClose":31.2383,"twentyDayClose":31.37,"sixtyDayClose":33.2723},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CEPI\",params:#limit:5,,,undefined,":[{"date":"2026-09-16","symbol":"CEPI","amount":0.251289,"announcedDate":"2026-09-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-16","defaultRemindTime":1789565400000,"name":"REX CRYPTO EQUITY PREMIUM INCOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-17","payableDate":"2026-09-16","currency":"USD","dateTimestamp":1789531200000,"payDate":"2026-09-17"},{"date":"2026-09-09","symbol":"CEPI","amount":0.2567,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-09","defaultRemindTime":1788960600000,"name":"REX CRYPTO EQUITY PREMIUM INCOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-10","payableDate":"2026-09-09","currency":"USD","dateTimestamp":1788926400000,"payDate":"2026-09-10"},{"date":"2026-09-02","symbol":"CEPI","amount":0.25153,"announcedDate":"2026-09-01","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-09-02","defaultRemindTime":1788355800000,"name":"REX CRYPTO EQUITY PREMIUM INCOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-09-03","payableDate":"2026-09-02","currency":"USD","dateTimestamp":1788321600000,"payDate":"2026-09-03"},{"date":"2026-08-26","symbol":"CEPI","amount":0.252177,"announcedDate":"2026-08-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-26","defaultRemindTime":1787751000000,"name":"REX CRYPTO EQUITY PREMIUM INCOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-27","payableDate":"2026-08-26","currency":"USD","dateTimestamp":1787716800000,"payDate":"2026-08-27"},{"date":"2026-08-19","symbol":"CEPI","amount":0.257833,"announcedDate":"2026-08-18","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-08-19","defaultRemindTime":1787146200000,"name":"REX CRYPTO EQUITY PREMIUM INCOME ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-08-20","payableDate":"2026-08-19","currency":"USD","dateTimestamp":1787112000000,"payDate":"2026-08-20"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CEPI\",market:\"US\",,,undefined,":[{"executeDate":"2025-01-28","recordDate":"2025-01-28","paymentDate":"2025-01-29","value":1.69835,"currency":"USD"},{"executeDate":"2025-02-25","recordDate":"2025-02-25","paymentDate":"2025-02-26","value":1.57775,"currency":"USD"},{"executeDate":"2025-03-25","recordDate":"2025-03-25","paymentDate":"2025-03-26","value":1.45915,"currency":"USD"},{"executeDate":"2025-04-29","recordDate":"2025-04-29","paymentDate":"2025-04-30","value":1.3286,"currency":"USD"},{"executeDate":"2025-05-29","recordDate":"2025-05-29","paymentDate":"2025-05-30","value":1.3881,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CEPI\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CEPI\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2635444279","title":"Press Release: Valneva Reports First Quarter 2026 Financial Results and Provides Corporate Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2635444279","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635444279?lang=en_us&edition=fundamental","pubTime":"2026-05-13 13:00","pubTimestamp":1778648400,"startTime":"0","endTime":"0","summary":"-- Cash position of EUR105.3 million as of end March 2026, excluding. proceeds from successful reserved offering completed in April 20261. -- Program launched in April to further reduce operating expenses. -- Pfizer expected to file regulatory submissions for Lyme disease vaccine. Lyon , May 13, 2026 -- Valneva SE , a specialty vaccine company, today reported its financial results for the first quarter ended March 31, 2026, provided key corporate updates, and updated its 2026 financial guidance. The condensed consolidated interim financial results are available on the Company's website .Valneva will provide a live webcast of its first quarter 2026 results conference call beginning. -- Total revenues were EUR30.9 million, including EUR30.5 million in product. sales, compared with EUR49.2 million and EUR48.6 million, respectively,in the first quarter of 2025, mainly reflecting the planned wind-down of. different shipment phasing to the U.S. Department of Defense. the first quarter of 202","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["R","BK4232","BK4139","CEPI","BK4022","BK4539","CHIM","VALN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629319097","title":"Press Release: Samsung Biologics Reports First Quarter 2026 Financial Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2629319097","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2629319097?lang=en_us&edition=fundamental","pubTime":"2026-04-22 14:50","pubTimestamp":1776840600,"startTime":"0","endTime":"0","summary":"-- Recorded Q1'26 revenue of KRW 1,257 billion and operating profit of KRW. -- Performance driven by full utilization across Plants 1 through 4 and. INCHEON, South Korea, April 22, 2026 /PRNewswire/ -- Samsung Biologics , a leading contract development and manufacturing organization , reported financial results for the first quarter of fiscal year 2026.In March, Samsung Biologics completed the acquisition of its Rockville manufacturing facility in Maryland, U.S. for USD 353 million, establishing its first U.S. manufacturing presence and further strengthening client proximity and supply chain resilience in a key market. Samsung Biologics also continues to evaluate strategic investments to further diversify its manufacturing network and support clients seeking regional supply alignment amid an evolving global operating env","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4099","BK4504","BK4550","BK4581","BK4604","CDMO","CEPI","BK4555","IEMG","TM","EMXC","03160","BK4139","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627741409","title":"European tissue jumbo roll prices start to rise in March as input cost increases erode margins","url":"https://stock-news.laohu8.com/highlight/detail?id=2627741409","media":"Fastmarkets","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627741409?lang=en_us&edition=fundamental","pubTime":"2026-04-14 12:00","pubTimestamp":1776139200,"startTime":"0","endTime":"0","summary":"Producers are announcing price hikes of up to €100 per tonne to offset soaring input costs, with further increases expected from April. Learn more.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"fastmarkets_highlight","url":"https://www.fastmarkets.com/insights/european-tissue-jumbo-roll-prices-start-to-rise-in-march-as-input-cost-increases-erode-margins/","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.fastmarkets.com/insights/european-tissue-jumbo-roll-prices-start-to-rise-in-march-as-input-cost-increases-erode-margins/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"fastmarkets_highlight","symbols":["CEPI"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":23,"code":"91000000","status":"200"}]}}